The non-coding portion of human genome is punctuated by a large number of multispecies conserved sequence (MCS) elements with largely unknown function. We demonstrate that MCSs are unevenly distributed in human introns with the majority of relatively short introns (<9 kb long) displaying no or a few MCSs and that MCS density reaching up to 10% of total size in longer introns. After correction for intron length, MCSs were found to be enriched within genes involved in development and transcription, whereas depleted in immune response loci. Moreover, many central nervous system tissues show a preferential expression of MCS-rich genes and MCS enrichment significantly correlates with gene functional complexity in terms of distinct protein domains. Analysis of human -mouse orthologous pairs indicated a significant association between intronic MCS density and conservation of protein sequence, promoter regions and untranslated sequences. Moreover, MCS density correlates with the predicted occurrence of human -mouse conserved alternative splicing events. These observations suggest that evolution acts on human genes as integrated units of coding and regulatory capacity and that functional complexity might represent a major source of negative selection on non-coding sequences. To substantiate our result, we also searched previously experimentally identified intronic regulatory elements and indicate that about half of these sequences map to an MCS; in particular, support to the notion whereby mutations in MCSs can result in human genetic diseases is provided, because three previously identified intronic pathological variations were found to occur within MCSs, and human disease and cancer genes were found significantly enriched in MCSs.
INTRODUCTION
The non-coding portion of human genome amounts to 99% (1) and a number of recent studies (reviewed in 2,3) have shown that this vast nucleotide puzzle is punctuated by multispecies conserved sequence (MCS) elements. These sequences are frequently shared among diverse mammalian species and many of them can be traced back to more distantly related organisms such as birds and fishes. Conversely, an extremely low sequence conservation outside coding regions has been identified when vertebrates and invertebrates genomes have been aligned (4, 5) . This latter observation allows itself to the interpretation that MCSs might represent a vertebratespecific feature underlying genome or organism complexity.
Despite the extensive efforts, the functional significance of these sequence elements is largely unknown. Recent studies indicated that at least a portion of MCSs might act as transcriptional regulators of nearby genes (5 -10) , with some of them also being able to elicit gene reporter expression (6, 7, 10) . In addition, distinct gene function categories have been associated (9) with gene deserts displaying high MCS densities, suggesting a role for non-random MCS distribution.
In other instances, MCSs have been shown to function in alternative splicing regulation (11) . Conversely, other authors (12) have suggested that only a few of MCSs might act as cis-acting gene regulators, because analysis of chromosome 21 indicated that MCS divergence and substitution pattern are independent of intergenic size or distance from nearby genes. MCSs located within intronic regions have attracted comparatively less attention when compared with intergenic MCSs. Still, introns cover about one-quarter of the human genome (1) and the concept of these sequences as mere junk has been confronted with increasing evidences suggesting their functional role in gene regulation and genome architecture.
The recent availability of multiple genomic sequences and the development of comparative algorithms allow a genomewide identification of MCSs; at the same time, a great wealth of gene annotation databases can be exploited for mining significant associations.
By integrating these resources, we demonstrate that MCSs are unevenly distributed in human introns, depending on intron size, gene function, expression pattern and presence of alternative splicing events. Moreover, we provide analysis of previously identified intronic regulatory elements and indicate that about half of these sequences map to an MCS; in particular, support to the notion whereby mutations in MCS can result in human genetic diseases is provided.
RESULTS

MCS identification and distribution analysis
An intron database was created as described in Materials and Methods: a total of 81 549 human introns were analyzed (55 553 mouse introns) amounting to 456 genomic megabases. MCSs were identified using phastCons predictions (13, 14) , which derive from human/chimpanzee/mouse/rat/dog/chicken/ pufferfish/zebrafish multiple alignments. A total of 238 005 human MCSs were retrieved (average frequency ¼ 0.522 kb) and 39.6% of human introns were found to contain at least one MCS. These sequences cover, on average, 3.99% of total intron length and their mean length amounts to 76 bp.
To analyze MCS distribution, introns were divided into length classes and MCS densities (conserved sequence length/ intron length) were calculated. Data are reported in Figure 1 and indicate that although variability in MCS density is observed for all intron length classes, a gradual shift toward higher MCS densities is observed with intron size increase. Extremely similar results were obtained when the same calculations were performed for mouse introns (Supplementary Material, Fig. S1 ).
Mapping MCSs onto experimentally verified regulatory regions
To gain insight into the biological significance of retrieved MCSs, we applied a direct, although not comprehensive, approach. We investigated whether previously experimentally identified intronic regulatory sequences matched with MCS locations. We, therefore, inspected the literature in search of experimentally verified human intronic sequences of established physiological significance and verified whether they partially or totally overlapped any phastCons element. A summary of this search is reported in Table 1 and indicates  that out of 19 and 25 intronic splicing or transcription regulatory elements, 8 and 12 , respectively, mapped to a phastCons sequence. One element constituted a conserved sequence with a role in adenosine deaminase-dependent RNA editing and mapped to an MCS. In seven instances, at least one mutation has been described, which affects one regulatory element and causes (or predisposes to) a human disease; three such mutations occur within phastCons functional elements.
MCSs are differentially represented depending on gene ontology
We next wished to identify those genes that are extremely rich or depleted in MCSs; because, as reported earlier, MCS density increases with intron size, we used MCS density calculations in intron length classes to sort out genes with higher or lower than expected MCS densities. For each gene, the expected MCS density was calculated on the basis of its individual intron lengths and then compared to the observed MCS density; in particular, for each intron, the expected MCS density (MCS exp ) is considered to be equal to the average density of the intron length class it belongs to. The normalized difference To investigate whether any preferential association existed between functional categories and MCS representation, human genes were classified into two groups depending on MCS density: genes displaying three times more or less MCS than expected (MCS ndev . 0.5 or MCS ndev , 20.5) were classified as MCS rich (656 genes) or poor (2634 genes), respectively. We next used GeneMerge (60) to retrieve significant associations; database annotations for the three categories designated by the Gene Ontology (GO) Consortium (molecular function, biological process and cellular component) were employed. Correction for multiple tests was applied to all statistical analyses. Significant associations with one or more ontology terms were identified for the three categories (Table 2 ; Supplementary Material, Table S1 ). As the whole hierarchy of ontology terms was used to identify significant associations, nested ontology categories were retrieved, which are often accounted for by the same gene sets (Supplementary Material, Table S1 ).
In the MCS-rich group, genes involved in development/ morphogenesis are significantly over-represented (biological process category); the same holds true for genes having a role in transcription and transcription regulation (both biological process and molecular function categories), as well as in nucleic acid metabolism. Coherently, the cellular component categorization identified gene products that localize to the nucleus as over-represented in this gene set. In addition, genes coding for ephrin receptors were significantly represented, upon classification, in molecular function categories. With respect to MCS-poor genes, over-represented biological process GO terms relate to a broad category that can be roughly described as response to stimulus/defense response/ immunity. In particular, the majority of identified molecular function categories are related to protease inhibitors. Moreover, genes coding for structural ribosome components and molecules involved in oxidoreductase activity were enriched in this gene set. Closer examination of single genes indicated that the majority of them encode mitochondrial ribosome constituents or electron transporters, a finding which is consistent with retrieved terms (ribosome and mitochondrion) in the cellular component categorization.
These same analyses gave similar results when mouse genes were analyzed (Supplementary Material, Table S2); the main difference being accounted for by the over-representation of genes involved in protein catabolism and proteolysis among MCS-poor genes.
MCS density correlates with structural complexity
We wished to verify whether higher gene product complexity in terms of different protein domains correlated with MCS density. We, therefore, analyzed the number of distinct non-redundant InterPro domains associated with each entry in our data set, which displayed at least one InterPro description. A significant trend was observed for gene products associated with a higher number of unique InterPro domains to display higher MCS ndev (Kruskall -Wallis P , 10 25 ; Supplementary Material, Fig. S2A ). This result is not biased by longer gene size or higher exon number in MCS-rich genes, because the latter are, on average, shorter and display a lower exon number compared with MCS-poor genes and with all other genes in the data set (Supplementary Material, Fig. S2B and C).
To verify whether any specific InterPro domain was enriched among genes displaying high or low MCS ndev, we used GeneMerge to retrieve significant associations with InterPro domains. As summarized in Table 3 , for both gene groups, significantly over-represented InterPro entries were identified (again Bonferroni correction was applied). In agreement with results from GO associations, genes displaying homeobox domains and helix -turn -helix motifs (involved in development and transcription, respectively) are over represented among MCS-dense genes. The same holds true for genes coding for ephrin family members.
As far as MCS-poor genes are concerned, the association pattern is more complicated, although it parallels, to some extent, GO term association results; in addition to already described associations (those related to defense response and oxidoreductase activity), genes coding for tumor antigens such as MAGE and GAGE result in a significant association. Moreover, an association was found with two InterPro domains characteristic of transcription factors, namely, Znfinger and KRAB (Kruppel-associated box). Closer examination revealed that these two associations are accounted for by largely overlapping gene sets (Supplementary Material,  Table S1 ), which map to paralogous gene clusters on chromosomes 19, 12 and X. These findings are in line with previous reports indicating that KRAB -ZNF proteins are accounted for by hundreds of family members organized in clusters and poorly conserved among vertebrates (61); indeed, no clear KRAB -ZNF gene has been identified in Fugu (62) and analysis of human-mouse KRAB -ZNF genes has shown that duplication and loss of ancestral cluster members has occurred independently in the two species (61) .
MCSs are differentially represented depending on gene expression pattern
To verify whether any correlation existed between intronic MCS density and expression level or pattern, we compared mean expression level (averaged over all tissues analyzed) and expression breadth (number of tissues in which a given gene is expressed) between MCS-rich and -poor genes: no significant difference was found. The same results were obtained when mouse genes were analyzed.
We then investigated whether variations in MCS density existed, depending on gene expression pattern; for any tissue, we calculated the differences between median expression levels of MCS-rich versus MCS-poor genes. Results for human genes are represented in Figure 2A and indicate that in most tissues, within the nervous system, MCS-rich genes are expressed at significantly higher levels (rank-sum test P , 0.01 or ,0.05, black and gray bars, respectively) Human Molecular Genetics, 2005, Vol. 14, No. 17 2537 when compared with MCS-poor genes, hypothalamus being the only exception among brain regions. The same holds true for genes expressed in skin, prostate, heart, uterus and lung. Conversely, all tested bone marrow cells and most peripheral blood cells behave in the opposite manner, with MCS-rich genes displaying significantly lower expression levels.
We next wished to verify whether differences existed in MCS density among tissue-specific genes. To this aim, we considered those genes expressed in a given tissue and in less than one-quarter of the total number of tissues, as previously suggested (63) . This procedure, although arbitrary, originates gene sets numerous enough for each tissue to allow statistical evaluation of differences.
We, therefore, calculated the median MCS ndev for genes expressed in each tissue and the median MCS ndev for all tissue-specific genes analyzed. Differences are plotted as histograms in Figure 2B and statistical significance was assessed by applying the rank-sum test. Again, a significant preferential expression of MCS-rich genes was noticed in many nervous system tissues, whereas the opposite situation was observed in fetal liver as well as in most bone marrow and peripheral blood cells in addition to lymph node and tonsil, possibly in line with the participation of the latter tissues in immune functions. These same analyses were performed for mouse genes (Supplementary Material, Fig. S3 ) and similar results were obtained. Yet, in the case of mouse, data concerning embryonal gene expression were available and indicated that although no significant deviation in MCS ndev was observed for genes expressed in the fertilized egg, blastocyst and for very early developmental stages (6.5 -8.5 d.p.c.), genes expressed at stages 9.5 and 10.5 d.p.c. displayed significantly higher MCS ndev .
MCS density correlates with conservation of protein sequence, upstream gene regions and alternative splicing in human -mouse orthologous pairs
To evaluate whether MCS density correlated with conservation in coding regions, for any gene in our database, we searched for a murine ortholog that could be unequivocally identified (Materials and Methods): a total of 3582 humanmouse orthologous gene pairs were retrieved. MCS ndev was then correlated with either the rate of non-synonymous substitution (dN) or the ratio of non-synonymous/synonymous substitutions (dN/dS); in both cases, a significant negative correlation was detected (r ¼ 20.2715, P , 10 260 and 20.20 and P , 10 234 , respectively). We next wished to verify whether any relationship existed between MCS density and gene upstream sequence conservation. To this aim, we exploited data deriving from a previously reported analysis of human -mouse orthologous gene conservation in 8 kb genomic regions upstream of coding start sites (64) . Out of 3055 previously studied genes, 1875 were also present in our study set. Comparison of MCS ndev with the number of conserved sequence block in upstream gene sequences resulted in a significant correlation (r ¼ 0.33, P , 10 26 ). Finally, we wished to investigate whether regulation of alternative splicing events might have a role in MCS fixation. We, therefore, took advantage of a previously reported (65) set of orthologous exons which are predicted to undergo humanmouse conserved alternative splicing events.
Initially, only genes that were also present in human data set were selected (660 out of 1580 previously reported).
Comparison of median MCS ndev (Fig. 3A) indicated that genes that display at least one conserved alternative splicing event (median MCS ndev ¼ 0.0051) have significantly higher MCS ndev when compared with all genes in our database (median MCS ndev ¼ 20.247; rank-sum test, P , 10 26 ); remarkably, MCS ndev progressively increases (Fig. 3B) when genes that display one, two or more than two alternative events were considered (Kruskall -Wallis P , 10
26 ). To better analyze the possible relationship between MCSs and alternative splicing, we selected all introns flanking predicted alternatively spliced exons (whether or not their genes were present in our data set) and all other introns from the same gene. We next searched for MCSs and then compared MCS density in introns located in 5 0 or 3 0 of a predicted conserved alternative spliced exons and all other introns extracted from the same genes. Data are reported in Figure 3C and indicate that introns flanking a conserved alternative exon are significantly enriched in MCSs (median MCS densities ¼ 0.015, 0.0398 and 0.029 for all introns, introns located in 5 0 , introns located in 3 0 , respectively; rank-sum test P , 10 23 ).
MCS density correlates with untranslated region conservation and length
We next retrieved, for each human entry in our database, information concerning 5 0 and 3 0 untranslated regions (UTRs). In particular, length and MCS density were calculated (Materials and Methods) for 5 0 and 3 0 UTRs; a significant correlation was observed between MCS ndev and both UTR length (r ¼ 0.14 for both 5 0 and 3 0 UTRs; P , 10 26 ) and MCS density (r ¼ 0.38 and 0.42 for 5 0 and 3 0 UTRs, respectively; P , 10 26 ).
MCSs are over represented in disease and cancer-related genes
To evaluate whether human genes involved in pathological processes displayed any difference in MCS density, we derived disease and cancer genes from the OMIM morbidmap and the Tumor Gene Database, respectively, and matched those that were also represented in our database: 933 disease and 152 tumor genes were obtained. For both disease and cancer genes, median MCS ndev was significantly higher (rank-sum test) when compared with the median of the , respectively). To evaluate whether overrepresentation of genes involved in transcription or development might be responsible for higher MCS density in the cancer and disease gene sets, we purged genes associated with these GO terms. In particular, 92 (60.5%) and 710 (74.8%) cancer and disease genes, respectively, were not associated with either development (GO: 0007275) or transcription (GO: 0006350); whereas in the case of cancer genes, the median MCS ndev (0.070) was significantly higher (rank-sum P , 10 24 ) when compared with the whole set of genes, no difference was noted for disease genes when the purged sets were analyzed.
DISCUSSION
In recent years, increasing evidences have suggested that intervening sequences have been contributing to eukaryote evolution (reviewed in 66). Intron presence allows massive proteome expansion through alternative splicing events (67) and has an impact on RNA metabolic processes (68 -70); as, in these cases, introns exert their functional role by being removed (although in a regulated way), the problem of within-genome intron evolution dynamics remains open to debate. Some authors (71) have proposed a model of 'selection for economy' whereby highly expressed genes are subjected to stronger pressure for intron shortening when compared with genes expressed at low levels or in few tissues. Conversely, Figure 2 . MCS differential representation in human tissue-specific genes. (A) Differences between median expression levels of MCS-rich versus MCS-poor genes (DExpression). Statistical evaluation was performed using the rank-sum test (P , 0.01 and ,0.05, black and gray bars, respectively). (B) Differences between median MCS ndev for each tissue and median MCS ndev for all tissue-specific genes (DMCS ndev ), using rank-sum test (P , 0.01 and ,0.05, black and gray bars, respectively). For this analysis, only genes expressed in a given tissue and in less than one-quarter of the total number of tissues were considered, as previously suggested (63) 
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the 'genomic design' model (72) , which our data strongly support, indicates that longer introns preferentially occur in tissue-specific genes due to increased regulatory complexity. Indeed, we have previously demonstrated that MCS fixation is responsible for intron size growth in humans (73); here, we show that intronic MCSs are specifically fixed in human genes depending on gene function and expression tissue, therefore, suggesting that the majority of these conserved sequences function as cis-acting gene regulators and, in turn, that intron elongation reflects cis-regulatory needs. In line with these considerations, the search for experimentally validated regulatory elements indicated that they map, in many instances, to MCSs (Table 1) . Our data indicate (Fig. 1) that the great majority of relatively short human introns display no or a few MCSs, whereas in the longer intron classes, median MCS density reaches up to 5% of total intron size; overall, MCS-containing introns represent ,40% in human (and ,35% in mouse). On one hand, it should be noted that introns lacking MCSs might still carry regulatory sequences which are not conserved (at least to the extent of being classified as an MCS), as demonstrated by the lack of correlation between many known functional elements and MCS positions (Table 1) . On the other hand, it is tempting to speculate that introns might provide a 2-fold tier in gene regulation by harboring cis-regulatory elements and by allowing adequate expression levels and mRNA processing. In the first instance, MCSs might play a pivotal role, whereas in the latter case, no MCS might be required, and intron removal might suffice to trigger downstream mRNA processing. Similar observations had been drawn upon analysis of Fugu genomic organization (62, 66, 74, 75) : in this organism, the few giant introns were suggested to play a role in gene regulation.
In line with previous suggestions, intronic MCSs can be expected to represent diverse functional categories, namely, chromatin structural elements (76), inter-chromosomal interactors (12) , transcriptional regulators (5 -10) or splicing modulatory elements (11) . In particular, this latter possibility has scarcely been considered, except for a previous report (11) that only analyzed conserved sequences immediately flanking splice sites. Table 1 indicates that experimentally identified intronic splicing regulators map, in many instances, to MCSs, suggesting that the need to control splicing processes contributes to the fixation of intronic conserved sequence elements. This is in line with the observation (73) that MCS distribution is not uniform across human intron sequences but shows an increase in regions flanking the splice sites. Still, alternative splicing events were reported to be poorly conserved between human and mouse (77) , an observation that casts doubts on the need to preserve MCSs to regulate largely divergent processes. Remarkably, it was Figure 3 . MCS distribution in relation to conserved alternative splicing events. Prediction of alternative splicing events conserved between human and mouse has been previously reported (65) . (A) Genes (n ¼ 660) that are predicted to display at least one conserved alternative splicing event (.0) show significantly higher MCS ndev when compared with all genes (n ¼ 7614). (B) Median MCS ndev progressively increases when genes that are predicted to display none (0; n ¼ 6954), one (1; n ¼ 529), two (2; n ¼ 96) or more than two (.2; n ¼ 35) conserved alternative events were considered. (C) Analysis of MCS density (x-axis) for introns (n ¼ 17 070) deriving from genes that are predicted to undergo at least one conserved alternative splicing event. Diamonds and asterisks indicate introns that are located in 5 0 and 3 0 (n ¼ 1467) of an alternatively spliced exon, respectively; circles indicate all introns (n ¼ 17 070).
Human
recently demonstrated (65) that a significantly higher humanrodent conservation of alternative splicing events is observed for genes involved in transcription regulation and development, as well as in central nervous system-specific genes. Indeed, our data indicate that genes displaying at least one predicted conserved alternative splicing event have significantly higher MCS ndev than those where alternative splicing events conserved in human and mouse have not been reported; moreover, MCS ndev progressively increases when genes that display two or more than two alternative events are considered. Consistently, introns flanking conserved alternatively spliced exons display, on average, significantly higher MCS densities than the average of other introns from the same genes.
In addition to splicing and transcription regulators, MCSs probably represent a heterogeneous class of functional elements; it is interesting to notice, in this respect, that the GO terms that are associated with MCS-rich genes closely reflect those that were associated with gene deserts displaying a high density of conserved sequence elements (9) , suggesting that intragenic and intergenic constraints might act in the same direction to preserve fine-tuned regulation of genes involved in pivotal processes such as development and transcription regulation. The same conclusion had also been put forward upon distribution analysis of sequence elements conserved between humans and fishes (10) . Nonetheless, it should be noticed that as evidenced from data concerning human and mouse embryonic/fetal gene expression, specific stages might exist during development when preferential expression of MCS-rich genes occurs. In fact, early mouse developmental stages (from fertilized egg to 8.5 d.p.c.) display no preferential expression of MCS-rich genes, which is instead observed for later stages. Mouse stages 9.5 -10.5 correspond to the first 5 weeks of human gestation; high-throughput gene expression data are only available for later human developmental stages (beyond 15 weeks for liver and 20 weeks after conception for brain and lung) and show no evidence of increased expression of MCS-rich genes compared with the adult tissue counterparts. Further gene expression studies are required to allow speculation on the role of highly conserved genes in human developmental stages, as well as on the possibility to provide a molecular definition for a phylotypic stage (fitting the hourglass model) for vertebrate development as previously attempted (78) .
Functional analysis of MCS-poor genes indicated that the great majority of them are involved in defense response. An accelerated divergence of coding regions had previously been shown for this functional category (79) and interpreted in terms of genetic conflict between host and pathogen. Although in the case of coding sequence divergence, positive selection and coevolution of protein -protein interactions have been invoked, the poor conservation of non-coding elements is probably more easily explained by relaxation of purifying selection pressure.
More generally, our data indicate that conservation of coding and non-coding sequences is highly correlated, suggesting that although different selective pressures might act on either, in many instances the same selection source (or absence of selection, i.e. neutral evolution) might be effective on both. Moreover, the density of conserved sequences in mammalian introns correlates with UTR length and conservation, as well as with conservation in upstream gene regions. This observation suggests that for a given gene, the evolution rates of its non-coding portions are closely coupled and, in turn, they parallel protein sequence evolution. A similar observation has been drawn upon analysis of Caenorhabditis elegans and C. briggsae orthologous genes (80) . In analogy to worms, evolution might therefore act on vertebrate genes as integrated units of coding and regulatory capacity and purifying selection might play a relevant role in preserving vital functions throughout. However, although the overall trend indicates a positive relationship between coding and noncoding sequence conservation, gene expression level and breadth do not show any association with intronic MCS density in either human or mouse. Previous studies (81 -83) had indicated that highly and broadly expressed genes displayed significantly lower coding sequence divergence and this was interpreted in terms of negative selection being more effective, especially in species with small population sizes as humans, on housekeeping genes. Instead, our data suggest that intronic MCS enrichment might correlate with gene functional complexity in terms of distinct protein domains and conserved alternative splicing events, strongly supporting the role of MCS as cis-acting regulators of complex genes. In addition, MCS-rich genes are over represented among central nervous system-specific genes, suggesting that MCSs might operate in assuring complex and fine-tuned regulatory events. In analogy, recent reports have indicated that tissue biology also plays a role in protein evolution and brain-specific genes have been shown to display relatively lower protein divergence (82, 84) . It is therefore tempting to speculate that although expression level and breadth might render purifying selection more effective at the coding sequence level, functional complexity might represent a source of negative selection on non-coding sequences and, to some extent, on proteins.
Recent reports have also indicated that broadly expressed genes are poorly represented among human disease genes, probably reflecting high frequency of embryonic lethality for mutations in housekeeping genes. Our data indicate that disease and cancer genes are, on average, enriched of intronic MCSs. This observation is in agreement with previous findings indicating that disease proteins exhibit a wider phylogenetic extent and are generally more conserved when compared with all human proteins (85) . Nonetheless, our data indicate that the higher MCS density in disease loci is mainly accounted for by genes that are involved in transcription or development, which possibly also account for higher protein conservation. Conversely, when the cancer gene set was purged from genes involved in these same processes, a significant enrichment in MCSs was still observed, suggesting that whatever the process they are involved in cancer genes need tight regulation and therefore are probably subjected to strong purifying selection for the maintenance of cisregulators.
As their discovery, the role of MCSs in intraspecific phenotypic variability, complex trait expression and human genetic disease has been debated. This issue has been addressed in a recent review (2) and the authors indicated that mutations in only one MCS (in intron 5 of LMBR1 gene) have now been 
MATERIALS AND METHODS
Human gene/intron database
For creation of the intron database, human genes that had been annotated in the NCBI Reference Sequence (RefSeq) collection were selected (reviewed or validated entries only); for mouse genes, 'Provisional' entries were also included. Genomic sequences and intron/exon boundaries were derived from the UCSC genome annotation database (http:// genome.ucsc.edu/cgi-bin/hgGateway hg17 assembly and mm5, May 2004 for human and mouse, respectively). Intronless genes were discarded, and for each gene, the transcript corresponding to the longest genomic sequence and containing the highest number of exons was selected. The data sets were constituted by 7614 human and 5550 mouse genes. For the identification of human -mouse orthologous pairs, the EnsMart database (http://www.ensembl.org/Multi/martview) was used and only entries representing unique best reciprocal hits were selected.
MCS retrieval and distribution analysis
MCS were obtained using phastCons predictions (13, 14) , which are based on a phylogenetic hidden Markov model and are available through the UCSC database (phastConsElements Table) . Only purely intronic phastCons elements were selected (i.e. MCS partially overlapping with exons was discarded). MCS density for intron length class k (dMCS k ) has been calculated as total class MCS length over total class intron length:
Expected MCS length for intron i belonging to length class k has been calculated as:
For each gene, we computed expected MCS densities (dMCS exp ) as:
These expected densities have been used in the evaluation of MCS ndev as reported in Results.
Functional element retrieval
Intronic functional element retrieval was performed by inspecting the literature for evidences of elements that accomplished the following criteria: experimental evidence for their function, purely intronic location and direct evidence for function in humans (those sequences that were experimentally tested in mice and inferred to also work in human because of sequence conservation were not included).
Gene classification
Gene associations with GO terms and their descriptions were performed by cross-referencing the UCSC hg17 kgXref table with the GO database; InterPro information was retrieved from the UCSC protein database (interProXref table) . InterPro associations were purged from redundancy using the 'entry2entry' table from the InterPro database, which reports existing parent/child relationships between domain entries. Association and description files were then created and significant associations between gene groups and GO terms or InterPro domains were identified using GeneMerge (60) .
The Tumor Gene Database (http://condor.bcm.tmc.edu/ ermb/tgdb/tgdb.html) was used to identify human genes involved in cancer processes. Disease genes were retrieved from OMIM (ftp://ftp.ncbi.nih.gov/repository/OMIM/ morbidmap).
Expression, alternative splicing and protein divergence data
Data on expression levels in human and mouse tissues were derived from previous studies (86, 87) : they are publicly accessible through the UCSC database (tables: gnfHumanAtlas2median and gnfHumanAtlas2medianExps; gnfMouseAtlas2median and gnfMouseAtlas2medianExps) and they are based on highdensity oligonucleotide arrays (GNF Gene Expression Atlas 2). We only considered probes corresponding to genes that had been included in our database; signals from duplicated probes on the same chip were averaged as well as replicates from the same tissue. A gene was considered to be expressed in a given tissue if its signal level was higher or equal to 200 arbitrary units (87) .
For analysis of conserved alternative splicing events, a previously reported (65) list of predicted conserved alternatively spliced exons was used; in particular, to obtain genes that were also present in our initial database, Ensembl gene Human Molecular Genetics, 2005, Vol. 14, No. 17 2543 entries provided by the authors were cross-mapped to RefSeq entries and, if represented in our database, allocated an MCS ndev value. For the analysis of single introns involved in alternative splicing events, all reported genes were used irrespective of their presence in our data set; all Ensembl transcripts corresponding to one described alternatively spliced gene were extracted from the UCSC database (ensGene and ensGtp tables) and the presence of an exon corresponding in sequence, length and position to the alternatively spliced one was checked. All gene intron sequences were then retrieved and trace was kept of introns located in either 5 0 or 3 0 of an alternatively spliced exon. To purge MCSs that might derive from alternative splicing events such as intron retention or inclusion of overlapping longer exons, all MCS that mapped to mRNA or EST entries in the UCSC database (tables all_mrna and all_est) were discarded from all introns analyzed.
Information concerning protein divergence (dN and dS) was obtained from the EnsMart database (http://www.ensembl.org/ Multi/martview).
UTR and upstream sequence information retrieval
For each transcript entry in our database, data concerning transcript start and end as well as coding sequence (CDS) boundaries were retrieved from the UCSC annotation tables; the difference between these positions was used to obtain UTR length after removal of introns. For MCS density calculations, we sought to eliminate all those MCSs that might correspond to spliced coding exons in an alternative transcript. To this aim, all transcripts totally or partially overlapping with those constituting our database were extracted from the following annotation tables: ensGene, refGene and knownGene (the latter combines all known protein-coding genes on the basis of protein data from SWISS-PROT, TrEMBL and TrEMBL-NEW and their corresponding mRNAs from GenBank). MCS that mapped to at least one coding exon in one transcript was eliminated.
Data concerning upstream sequence conservation have been previously reported (64) and refer to 8 kb genomic regions upstream of CDS starts sites.
